Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 21;6(8):2557–2577. doi: 10.1182/bloodadvances.2021005720

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

PMC Copyright notice

Figure 1. — TAFAZZIN is dispensable for fetal liver myelopoiesis. (A) Flow cytometry gating strategy for fetal liver myeloid progenitor populations. Common myeloid progenitors (CMPs), megakaryocyte-erythrocyte progenitors (MEPs), and granulocyte-macrophage progenitors (GMPs) were identified based on CKIT, SCA1, CD16/32, and CD34 staining. (B) Myeloid progenitors were enumerated in the WT or TAFAZZIN-KO fetal livers harvested at embryonic days 14, 14.5, 15, 15.5, and 16. The numbers of fetal livers included in the analysis is indicated. (C) A focus on the frequency of GMPs, combined from the other panels, within the fetal livers of WT or TAFAZZIN-KO embryos shows as significant difference only at E14. Error bars indicate the mean ± SD. t tests were performed. *P < .05. Other results are not statistically significant.